Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TELA Bio (TELA) Asset Writedowns and Impairment (2018 - 2026)

TELA Bio has reported Asset Writedowns and Impairment over the past 8 years, most recently at $818000.0 for Q4 2025.

  • For Q4 2025, Asset Writedowns and Impairment fell 41.24% year-over-year to $818000.0; the TTM value through Dec 2025 reached $2.4 million, down 20.14%, while the annual FY2025 figure was $2.4 million, 20.14% down from the prior year.
  • Asset Writedowns and Impairment for Q4 2025 was $818000.0 at TELA Bio, up from $632000.0 in the prior quarter.
  • Over five years, Asset Writedowns and Impairment peaked at $1.4 million in Q4 2024 and troughed at $57000.0 in Q4 2022.
  • A 5-year average of $501700.0 and a median of $568000.0 in 2023 define the central range for Asset Writedowns and Impairment.
  • Biggest five-year swings in Asset Writedowns and Impairment: tumbled 72.38% in 2021 and later skyrocketed 640.35% in 2023.
  • Year by year, Asset Writedowns and Impairment stood at $105000.0 in 2021, then crashed by 45.71% to $57000.0 in 2022, then skyrocketed by 640.35% to $422000.0 in 2023, then skyrocketed by 229.86% to $1.4 million in 2024, then crashed by 41.24% to $818000.0 in 2025.
  • Business Quant data shows Asset Writedowns and Impairment for TELA at $818000.0 in Q4 2025, $632000.0 in Q3 2025, and $280000.0 in Q2 2025.